That's essential, because the way a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and work. To put it simply, we have to know how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error process (white house). Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're created to do. This was an advancement practically nobody saw. But it's going to have profound implications for treating disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be a lot of investment chances in this space, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (longtime readers). That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be surprised if it drew back maybe substantially before going greater - toxic tech 5 tech darlings. I have actually been covering bitcoin for a very long time now. Among the first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were primarily informing readers. But that's not the big concern any longer. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. Mass, Mutual is a trusted 170-year-old institution. So think about that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. jeff brown 2021 stock picks. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of excellent personal business on the edge of striking the general public markets And I've been dealing with a brand-new method for you to invest even before these companies go public.
This chance has actually been constructing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover out all the information. Go right here to schedule your area for totally free.
Emma Walsh here, handling editor of the Journal. Regular Diary readers know that tech isn't our typical beat (jeff brown top stock pick 2021). And when it pertains to tech investing, we leave it to the experts. Thankfully, we have several such specialists in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing professionals we understand (last week). In truth, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the big image and predict what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and much more. These trends are experiencing rapid growth and developing extraordinary chances for investors. I wish to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. jeff brown biotech stock. But despite what lots of readers might believe, this is a pattern that's simply starting. Despite the fact that the COVID-19 pandemic interrupted supply chains in 2015, an excellent 250 million 5G-enabled devices were still offered.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown stock predictions). Losing two months of production and sales really affects how lots of 5G gadgets are sold in the fiscal year. When you think about all of that, offering 250 million units is remarkable. More importantly, the hold-ups triggered by the pandemic produced a lots of bottled-up demand. Which demand is now going to be pressed into 2021. In truth, I predict that more than 500 million 5G gadgets will be shipped in 2021 - artificial intelligence. Which's not my only 5G forecast When I have actually discussed 5G in the past, I've described its three different phases.
In Stage 2, 5G gadgets go on sale. 5G phones and other items start to reach customers. And in Phase 3, 5G services start to be used (the legacy report predictions). That's when we start to see applications working on 5G networks. Think about things like enormous multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Stage 3 by this summertime. This starts something of a virtuous cycle: The majority of people do not really appreciate the innovation. But they will care if there are amazing applications that can just be accessed with a 5G phone.
That results in more 5G apps being established. In fact, 5G is going to open up a suite of amazing applications: self-driving cars and trucks, the Internet of Things, robotic surgical treatment, and more. All of these innovations need 5G. The financial investment chances moving forward will be huge. Stepping away from 5G, the next crucial innovation I visualize in 2021 is CRISPR genetic editing. CRISPR stands for "clustered frequently interspaced short palindromic repeat." It's a mouthful. But it's one of the most interesting advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software application.
The program can crash or not work properly. CRISPR uses a similar idea however with our genetic code. "Typos" in our genome can cause illness. CRISPR can fix these "typos." For several years, CRISPR was primarily a niche technology that wasn't well understood. And throughout that time, there were really only three companies operating in this space. But things are changing. CRISPR is no longer simply theoretical. We're seeing real results. We're treating illness and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR companies is going public and delivering extraordinary returns. This entire market is effectively a greenfield opportunity.
There's space for numerous companies to exist in this space. genetic sequencing companies jeff brown. And there will be more. That's my forecast for CRISPR in 2021. I forecast that 2 or 3 more hereditary editing companies will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things occurring at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software can precisely anticipate the folding of a protein based exclusively on its amino acid sequence with 92. 4% precision. That is very important due to the fact that the method a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error process. And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're developed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however a number of drug treatments produced using this innovation. This was one of those advancements that nearly nobody observed. But it's going to have profound implications for curing illness. And, obviously, there will be a lot of investment chances in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it pulled back possibly considerably before going greater. I've been covering bitcoin for a very long time now. Among the first research study reports I ever published was on bitcoin - diplomatic relations. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for any person who followed my suggestion. However at the time of that initial suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
However no one is asking that concern anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. melania trump. Mass, Mutual is a 150-year-old organization. So think about that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the info depends on date since February 2021, however we could not individually validate this claim. Provided Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like ability to select winning technology stocks. He spent more than 25 years investigating innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an exceptional point of view on the market. He's constantly on the hunt for brand-new opportunities, and he shares numerous of his finest picks in the Future Report.
That's high praise, however it's not ridiculously reasoned. Brown has an excellent reputation as a stock-picker, and he effectively predicted a few of the most significant financial events of the past twenty years. Although he does not appear to launch his choices to the general public, the service's success is a direct sign of Brown's stock-picking prowess. Nobody on Wall Street gets it ideal every time, however Jeff Brown's accurate forecasts have actually made him legions of devoted followers. That says a lot about his ability. The Future Report is published by Brownstone Research, a prominent monetary research publisher. Brownstone Research uses numerous research study services with a wide range of specializations - jeff brown biotech stock pick for 2020.
The business is likewise connected with Bonner & Partners, another well-respected research study publisher - jeff brown biotech genome sequencing. On its site, Brownstone says its objective is to provide retail investors with professional-grade research study: "For too long, the best financial investment research study has actually not been offered to individual investors. It has actually been generally scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth clients. second wave. The objective of Brownstone Research study is to make that kind of proprietary research study offered to any financiers aiming to acquire an edge in the marketplaces. The objective is easy to deliver unique and successful investment research study discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research, and he also functions as the firm's Chief Investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After decades of steady success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout most of America. If you know even a bit about the market, you understand that he has a credibility as a King Midas of sorts. jeff brown 2021 predictions. Everything he touches turns to gold! Jeff is well conscious of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In fact, Brown thinks S.A.V. jeff bezos. could be "the biggest pattern of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding 2 advanced innovations: expert system and electrical vehicles. Musk hopes the combination will assist him establish the first fully-autonomous, self-driving cars ever. It's absolutely nothing except the automotive market's Holy Grail. As you understand, electric vehicles and self-driving car stocks have been huge this year, but the Wall Street machine has approved hype without much tangible outcome. Regardless of a drastic increase in competition over the previous few years, Brown still thinks Musk has the best possibility of putting it all together.
tech could be the magic string that ties everything together. S.A.V. represents Shared Autonomous Vehicle, and it might be the future of transport. Essentially, this innovation would allow you to lease out your vehicle as an autonomous, self-driving taxi when you're not using it. You just get out of the cars and truck and press a button on an app that informs the car to "sign up with the fleet." Next thing you know, you're relaxing on your sofa while your car shuttles ride-sharers around town. Most importantly, you get to keep a large piece of the profits. It sounds outrageous, but it might be closed than you believe.